title: Auranofin.
authors.affiliation: Rheumatic Disease Unit, McMaster University, Hamilton, Ontario, Canada.
authors.forename: W F
authors.initials: WF
authors.lastname: Kean
authors.forename: L
authors.initials: L
authors.lastname: Hart
authors.forename: W W
authors.initials: WW
authors.lastname: Buchanan
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D018501:Antirheumatic Agents / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use; D001310:Auranofin / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D006801:Humans; D007223:Infant; D007596:Joints / Q000187:drug effects / Q000473:pathology / Q000503:physiopathology; D008875:Middle Aged; D011859:Radiography; D016032:Randomized Controlled Trials as Topic; D012216:Rheumatic Diseases / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000473:pathology; D016896:Treatment Outcome
chemical_list: D018501:Antirheumatic Agents; D001310:Auranofin